FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

Surgery Partners, Inc. SGRY

Weak   broader-coverage candidate · Surgery Partners, Inc.

On FrontierLab's discovery record since 2026-09-24 (12 days ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-25), not the curated Frontier signal.
⚠ Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.

Key quality signals

Revenue growth (YoY)4%
Gross margin21.4%
Gross profits / assets0.09
Rule of 4015.9
Net margin11.9%
Cash runway (months)—
PEG—
Price / sales0.6

Quality checklist

Fundamentals — snapshot as of 2026-09-25

StageEstablished
Share issuance (YoY)1.5% · modest issuance
Moat—
TAM—
P/E (trailing)—
EPS (trailing)$-0.69
Burn multiple—
Gross-margin trend (pts)-2.3
Cash / assets0.03
Net debt / EBITDA4
Statements as ofQ2 FY2026 · filed 2026-08-10

Momentum context — a snapshot from 2026-09-25, not current

Price at surface$14.20 (as of 2026-09-25)
52-week range$11.41 – $23.44
% off 52-wk high-39.4%
RSI (14)49
Relative volume0.8×

Risk flags

Thin gross margin — keeps little of each sales dollar (judge it against its industry).Parabolic one-day spike (+16%) in the last month — extreme single-day moves tend to mean-revert.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-09-25 (end-of-day). How grades are computed →